Is a Positive NECPAL in ICU Patients Associated With Higher Mortality

Launched by CONSORCI SANITARI DE L'ALT PENEDÈS I GARRAF · Jun 4, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a tool called the NECPAL scale to see if it can help identify patients in the Intensive Care Unit (ICU) who are at a higher risk of dying within 90 days of being admitted. The goal is to understand whether using this scale can improve care for patients with serious health issues.

To be eligible for this study, participants need to be 75 years or older and admitted to the ICU at the study center. They must also be able to give consent to participate, either by themselves or through a legal representative. However, if a patient passes away within the first 24 hours of being admitted to the ICU, they won't be included in the study. This trial is not yet recruiting participants, but it aims to gather important information that could help in treating critically ill patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• * Patients who meet all of the following inclusion criteria may be included in the study:
• • Men and women aged 75 years or older.
• • Admission to the ICU of the study center.
• • Legal capacity to provide informed consent.
• • Signed informed consent for study inclusion, either by the participant or their legal representative.
• Exclusion Criteria:
• Participants who meet any of the following exclusion criteria may not be included in the study:
• • -Death within the first 24 hours of ICU admission.